Connect
MJA
MJA

Substance‐related disorders

Addiction medicine

Street GP

Raymond C Seidler

Med J Aust 2002; 177 (2): 108

Research

Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting

Noeline C Latt, Stephen Jurd, Jennie Houseman and Sonia E Wutzke

Med J Aust 2002; 176 (11): 530-534 Free

New Drugs, Old Drugs

The pharmacotherapy of smoking cessation

Matthew J Peters and Lucy C Morgan

Med J Aust 2002; 176 (10): 486-490 Free

EBM: Trials on trial

Which substitution pharmacotherapy is most effective in treating opioid dependence?

Linda R Gowing, Robert L Ali and Jason M White

Med J Aust 2002; 176 (10): 493-494

EBM in action

Is subcutaneous or intramuscular naloxone as effective as intravenous naloxone in the treatment of life-threatening heroin overdose?

Jason Wasiak and Ornella Clavisi

Med J Aust 2002; 176 (10): 495

Lessons from practice

Death and paramethoxyamphetamine — an evolving problem

Roger W Byard, Nicholas G Rodgers, Ross A James, Chris Kostakis and Andrew M Camilleri

Med J Aust 2002; 176 (10): 496 Free

Letters

Separating politics and scientific research on heroin prescription

Alex D Wodak, Alison J Ritter and Charles RR Watson

Med J Aust 2002; 176 (10): 449

Letters

In reply: Separating politics and scientific research on heroin prescription

Wayne D Hall, Richard P Mattick and Jo Kimber

Med J Aust 2002; 176 (9): 450

Snapshot

Digit loss following misuse of temazepam

Gerald FX Feeney and Harry H Gibbs

Med J Aust 2002; 176 (8): 380 Free

Letters

HIV among injecting drug users of Indo-Chinese ethnicity in Victoria

Jane S Hocking, Peter G Higgs, Cathy M Keenan and Nick Crofts

Med J Aust 2002; 176 (4): 191-192

For debate

Breaking the deadlock over an Australian trial of injectable opioid maintenance

Wayne D Hall, Jo Kimber and Richard P Mattick

Med J Aust 2002; 176 (2): 72-73

Letters

How much alcohol is drunk in Australia in excess of the new Australian alcohol guidelines?

Tim R Stockwell, Penny Heale, Tanya N Chikritzhs, Paul Dietze and Paul Catalano

Med J Aust 2002; 176 (2): 91-92

Letters

Is bupropion (Zyban) causing deaths?

Simon C Chapman and Konrad Jamrozik

Med J Aust 2002; 176 (3): 134

Updates in medicine

Alcohol and drugs

Alex D Wodak

Med J Aust 2002; 176 (1): 5

Public health

How many dependent heroin users are there in Australia?

Wayne D Hall, Joanne E Ross, Michael T Lynskey, Matthew G Law and Louisa J Degenhardt

Med J Aust 2000; 173 (10): 528-531

For debate

Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?

Simon R Lenton and Kim M Hargreaves

Med J Aust 2000; 173 (5): 260-263

Personal perspective

The New South Wales Drug Summit: a view from a local foreign observer

Jeffrey H Samet

Med J Aust 2000; 173 (5): 264-265

Viewpoint

An analgesic role for cannabinoids

Christopher W Vaughan and Macdonald J Christie

Med J Aust 2000; 173 (5): 270-272

Editorials

Alcohol: the good, the bad and the ugly

Greg Whelan and Alan T Gijsbers

Med J Aust 2000; 173 (5): 231-232

Editorials

Alcohol and cardiovascular disease: still a research priority?

Timothy R Stockwell

Med J Aust 2000; 173 (3): 116-117

Viewpoint

Is the grass greener? The link between cannabis and psychosis

Diana R McKay and Christopher C Tennant

Med J Aust 2000; 172 (6): 284-286

Editorials

Is naltrexone a cure for heroin dependence?

Wayne D Hall and Alex Wodak

Med J Aust 1999; 171 (1): 9-10

Healthcare

A pilot study of naltrexone-accelerated detoxification in opioid dependence

James R Bell, Malcolm R Young, Sibyl C Masterman, Amanda Morris and Richard P Mattick

Med J Aust 1999; 171 (1): 26-30

For debate

"Acculturating" heroin use

Matt D Gaughwin

Med J Aust 1996; 164 (11): 692-693 Free

Viewpoint

Heroin addiction: the science and ethics of the new treatment pluralism

Matt D Gaughwin and Philip Ryan

Med J Aust 1999; 170 (3): 129-130